HIV + Hepatitis Policy Institute To CMS: Act Against Texas Insurer Not Covering HIV Meds

The HIV + Hepatitis Institute is urging CMS to take immediate enforcement action against a Texas insurer that the group alleges is “making a mockery” of formulary design requirements by limiting coverage of standard HIV treatments and is discriminating against HIV patients by placing most drugs in high-costs tiers in violation of Affordable Care Act rules. Ahead of 2024 open enrollment season, CMS must ensure all plans are covering HIV treatments as required, the Institute adds. In a complaint filed...